CN104839695A - Non-complete nutritional formula food for inflammatory bowel disease - Google Patents
Non-complete nutritional formula food for inflammatory bowel disease Download PDFInfo
- Publication number
- CN104839695A CN104839695A CN201510195668.0A CN201510195668A CN104839695A CN 104839695 A CN104839695 A CN 104839695A CN 201510195668 A CN201510195668 A CN 201510195668A CN 104839695 A CN104839695 A CN 104839695A
- Authority
- CN
- China
- Prior art keywords
- food
- oil
- inflammatory bowel
- nutritional formulas
- several
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 84
- 208000022559 Inflammatory bowel disease Diseases 0.000 title claims abstract description 60
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 55
- 239000003814 drug Substances 0.000 claims abstract description 48
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 39
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 31
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 30
- 239000011707 mineral Substances 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 28
- 235000010755 mineral Nutrition 0.000 claims abstract description 28
- 150000001413 amino acids Chemical class 0.000 claims abstract description 22
- 230000036541 health Effects 0.000 claims abstract description 22
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 22
- 235000015097 nutrients Nutrition 0.000 claims abstract description 9
- 238000005516 engineering process Methods 0.000 claims abstract description 4
- 239000004519 grease Substances 0.000 claims abstract 7
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 30
- 239000003921 oil Substances 0.000 claims description 26
- 235000019198 oils Nutrition 0.000 claims description 26
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 24
- 229940024606 amino acid Drugs 0.000 claims description 21
- 235000001014 amino acid Nutrition 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 16
- 239000000686 essence Substances 0.000 claims description 15
- 244000144725 Amygdalus communis Species 0.000 claims description 14
- 235000020224 almond Nutrition 0.000 claims description 14
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 235000009467 Carica papaya Nutrition 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 240000000171 Crataegus monogyna Species 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- 241001264174 Cordyceps militaris Species 0.000 claims description 8
- 240000000588 Hericium erinaceus Species 0.000 claims description 8
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 8
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 8
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 7
- 240000002900 Arthrospira platensis Species 0.000 claims description 7
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 7
- 244000270834 Myristica fragrans Species 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 244000088415 Raphanus sativus Species 0.000 claims description 7
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 7
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 7
- 240000006365 Vitis vinifera Species 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 235000013557 nattō Nutrition 0.000 claims description 7
- 239000001702 nutmeg Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 241000190633 Cordyceps Species 0.000 claims description 6
- 241000195620 Euglena Species 0.000 claims description 6
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 6
- 244000223014 Syzygium aromaticum Species 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000010903 husk Substances 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 108010038807 Oligopeptides Proteins 0.000 claims description 5
- 102000015636 Oligopeptides Human genes 0.000 claims description 5
- 235000021323 fish oil Nutrition 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 241000132012 Atractylodes Species 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 4
- 244000111489 Gardenia augusta Species 0.000 claims description 4
- 229920002527 Glycogen Polymers 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- 229940096919 glycogen Drugs 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 229910052750 molybdenum Inorganic materials 0.000 claims description 4
- 239000011733 molybdenum Substances 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 235000007215 black sesame Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 239000011572 manganese Substances 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 235000006487 Euryale ferox Nutrition 0.000 claims description 2
- 244000268590 Euryale ferox Species 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 244000197580 Poria cocos Species 0.000 claims description 2
- 235000008599 Poria cocos Nutrition 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 241000586290 Suaeda salsa Species 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229940106134 krill oil Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- 235000019175 phylloquinone Nutrition 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 2
- 229960001898 phytomenadione Drugs 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 8
- 210000004317 gizzard Anatomy 0.000 claims 4
- 239000012528 membrane Substances 0.000 claims 4
- 244000189799 Asimina triloba Species 0.000 claims 3
- 235000006264 Asimina triloba Nutrition 0.000 claims 3
- 241001647745 Banksia Species 0.000 claims 3
- 240000004307 Citrus medica Species 0.000 claims 3
- 235000001938 Citrus medica Nutrition 0.000 claims 3
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims 3
- 240000004638 Dendrobium nobile Species 0.000 claims 3
- 235000018958 Gardenia augusta Nutrition 0.000 claims 3
- 241000220317 Rosa Species 0.000 claims 3
- 241000124033 Salix Species 0.000 claims 3
- 241001145025 Saussurea involucrata Species 0.000 claims 3
- 229940082787 spirulina Drugs 0.000 claims 3
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 2
- 241000219226 Acer truncatum Species 0.000 claims 1
- 241000345998 Calamus manan Species 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 235000013234 Rhus glabra Nutrition 0.000 claims 1
- 240000008599 Rhus glabra Species 0.000 claims 1
- 235000019774 Rice Bran oil Nutrition 0.000 claims 1
- 235000010841 Silybum marianum Nutrition 0.000 claims 1
- 244000272459 Silybum marianum Species 0.000 claims 1
- 229920000377 Sinistrin Polymers 0.000 claims 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 235000001122 chang geng bian tao Nutrition 0.000 claims 1
- -1 citrulling Chemical compound 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 235000013312 flour Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 235000009973 maize Nutrition 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 235000012950 rattan cane Nutrition 0.000 claims 1
- 239000008165 rice bran oil Substances 0.000 claims 1
- 235000015170 shellfish Nutrition 0.000 claims 1
- 229940001941 soy protein Drugs 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 abstract description 34
- 239000011782 vitamin Substances 0.000 abstract description 34
- 229930003231 vitamin Natural products 0.000 abstract description 30
- 235000013343 vitamin Nutrition 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 16
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000029087 digestion Effects 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 4
- 239000010839 body fluid Substances 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000009977 dual effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000006870 function Effects 0.000 description 23
- 208000002551 irritable bowel syndrome Diseases 0.000 description 23
- 150000003722 vitamin derivatives Chemical class 0.000 description 19
- 230000000968 intestinal effect Effects 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 12
- 239000003925 fat Substances 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 240000006432 Carica papaya Species 0.000 description 6
- 208000011231 Crohn disease Diseases 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 241001523681 Dendrobium Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 241001127714 Amomum Species 0.000 description 4
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 240000003553 Leptospermum scoparium Species 0.000 description 4
- 235000015459 Lycium barbarum Nutrition 0.000 description 4
- 244000179970 Monarda didyma Species 0.000 description 4
- 235000010672 Monarda didyma Nutrition 0.000 description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 4
- 241000018646 Pinus brutia Species 0.000 description 4
- 235000011613 Pinus brutia Nutrition 0.000 description 4
- 244000134552 Plantago ovata Species 0.000 description 4
- 235000003421 Plantago ovata Nutrition 0.000 description 4
- 239000009223 Psyllium Substances 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000035508 accumulation Effects 0.000 description 4
- 235000020235 chia seed Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940010454 licorice Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940070687 psyllium Drugs 0.000 description 4
- 235000013548 tempeh Nutrition 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 206010009900 Colitis ulcerative Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 240000001972 Gardenia jasminoides Species 0.000 description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020774 essential nutrients Nutrition 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000014105 formulated food Nutrition 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000006180 nutrition needs Nutrition 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000092665 Atractylodes macrocephala Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000233779 Cyclocarya paliurus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000003385 Diospyros ebenum Nutrition 0.000 description 2
- 241000792913 Ebenaceae Species 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000037208 balanced nutrition Effects 0.000 description 2
- 235000019046 balanced nutrition Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 235000007877 Diospyros australis Nutrition 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241001528187 Paliurus Species 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000002577 Prunus nigra Species 0.000 description 1
- 235000010875 Prunus nigra Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001466077 Salina Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 235000018288 Vitex doniana Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000011194 good manufacturing practice Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940096402 milk thistle seed Drugs 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 208000030683 polygenic disease Diseases 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明属于药食同源类配方与新资源食品技术领域,具体是将 “药食同源之中药”的传统中医精髓理论和新资源食品有机结合起来,添加以短肽、益生元、氨基酸、碳水化合物、有保健功能的油脂、复合维生素、复合矿物质为辅料制成的防治炎性肠病的全营养配方食品、特定全营养配方食品或非全营养配方食品。 The invention belongs to the technical field of medicine and food homologous formula and new resource food, and specifically combines the traditional Chinese medicine essence theory of "medicine and food homologous Chinese medicine" with new resource food, and adds short peptides, prebiotics, amino acids, Carbohydrates, fats with health functions, multi-vitamins, and multi-minerals are complete nutritional formula foods for the prevention and treatment of inflammatory bowel disease, specific complete nutritional formula foods or non-complete nutritional formula foods.
背景技术 Background technique
炎性肠病,简称IBD,是一种特殊的慢性肠道炎症性疾病,主要包括克罗恩病(CD)和溃疡性结肠炎(UC),近30年来,我国IBD发病率有不断攀升的趋势,根据国内文献报道,近5年的病例数是上世纪90年代同期的8倍,IBD已逐渐成为我国消化科的常见病,很多老百姓口中的“慢性肠炎”很可能就是IBD,IBD患者肠道不能正常吸收进食的碳水化合物、蛋白质、脂肪、维生素及多种微量元素,加上肠道炎症或服用的药物可能造成食欲不佳,因此IBD常伴随着不同程度的营养不良,甚至影响小孩正常的生长发育,营养支持对IBD症状缓解及促进愈合有重要的作用,因此保持自身良好的营养状态是治疗IBD一个重要的部分,IBD并没有存在专门的特殊饮食,不同人能耐受的食物有异,因此IBD总的饮食原则是保证自己膳食平衡同时避免一些使疾病恶化的食物,很多专家都认为,炎性肠病并不可怕,只要养成健康的生活方式,保证进食、休息、用药规律,定期随访监测病情,炎性肠病是可以控制的的碳水化合物、蛋白质、脂肪、维生素及多种微量元素,IBD 的病因和发病机制尚未完全明确,已知肠道粘膜免疫系统异常反应所导致的炎症反应在IBD发病中起重要作用,认为这是由多因素相互作用所致,主要包括环境、遗传、感染和免疫因素,一、环境因素近几十年来,IBD(UC和CD)的发病率持续增高,这一现象首先出现在社会经济高度发达的北美、北欧,继而是西欧、南欧,最近才是日本、南美,这一现象反映了环境因素微妙但却重要的变化,如饮食、吸烟或暴露于其他尚不明确的因素,二、遗传因素,IBD发病的另一个重要现象是IBD患者一级亲属发病率显著高于普通人群,而患者的配偶发病率不增加,瑞典一项大规模的研究发现,CD发病率单卵双胞显著高于双卵双胞,已有大量关于IBD相关基因的报道,早期研究主要集中在HLA等位基因以及细胞因子基因多态性上,但报道的结果不一,主要可能与不同种族、人群遗传背景有关,近年对基因组进行定位克隆,在IBD家族的大样本研究发现,IBD的易感点位于第3、7、12、16号染色体上,有关研究尚在深入进行中,认为,IBD不仅是多基因病,而且也是遗传异质性疾病(不同人由不同基因引起),患者在一定的环境因素作用下由于遗传易感而发病,三、感染因素微生物在IBD发病中的作用一直受到重视,但至今尚未找到某一特异微生物病原与IBD有恒定关系,有研究认为副结核分枝杆菌及麻疹病毒与CD有关,但证据尚缺乏说服力。近年关于微生物致病性的另一种观点正日益受到重视,这一观点认为IBD(特别是CD)是针对自身正常肠道菌丛的异常免疫反应引起的,有两方面的证据支持这一观点,一方面来自IBD的动物模型,用转基因或敲除基因方法造成免疫缺陷的IBD动物模型,在肠道无菌环境下不会发生肠道炎症,但如重新恢复肠道正常菌丛状态,则出现肠道炎症, Inflammatory bowel disease, referred to as IBD, is a special chronic intestinal inflammatory disease, mainly including Crohn's disease (CD) and ulcerative colitis (UC). In the past 30 years, the incidence of IBD in China has been rising. According to domestic literature reports, the number of cases in the past five years is 8 times that of the same period in the 1990s. IBD has gradually become a common disease in gastroenterology in China. The "chronic enteritis" that many people talk about is probably IBD. The intestinal tract cannot normally absorb carbohydrates, protein, fat, vitamins and various trace elements, and intestinal inflammation or medication may cause poor appetite. Therefore, IBD is often accompanied by different degrees of malnutrition, and even affects children's normal health. Nutritional support plays an important role in relieving IBD symptoms and promoting healing. Therefore, maintaining a good nutritional status is an important part of the treatment of IBD. There is no special diet for IBD. Different people can tolerate different foods. Therefore, the general dietary principle of IBD is to ensure a balanced diet while avoiding some foods that make the disease worse. Many experts believe that inflammatory bowel disease is not terrible, as long as you develop a healthy lifestyle and ensure regular eating, rest, and medication , Regular follow-up and monitoring of the condition. Inflammatory bowel disease is controllable carbohydrates, protein, fat, vitamins and various trace elements. The etiology and pathogenesis of IBD are not yet fully clear. It is known that the abnormal reaction of the intestinal mucosal immune system leads to The inflammatory response plays an important role in the pathogenesis of IBD, which is believed to be caused by the interaction of multiple factors, mainly including environmental, genetic, infection and immune factors. First, environmental factors In recent decades, the incidence of IBD (UC and CD) This phenomenon first appeared in North America and Northern Europe with highly developed socioeconomics, then in Western Europe and Southern Europe, and more recently in Japan and South America. This phenomenon reflects subtle but important changes in environmental factors, such as diet, smoking, etc. Or exposure to other unclear factors. Second, genetic factors. Another important phenomenon in the onset of IBD is that the incidence rate of first-degree relatives of IBD patients is significantly higher than that of the general population, while the incidence rate of the patient's spouse does not increase. A large-scale study in Sweden Studies have found that the incidence of CD in monozygotic twins is significantly higher than that in dizygotic twins. There have been a large number of reports on IBD-related genes. Early studies mainly focused on HLA alleles and cytokine gene polymorphisms, but the reported The results are mixed, which may be related to the genetic background of different races and populations. In recent years, positional cloning of the genome has been carried out. In large-scale studies of IBD families, it has been found that the susceptibility points of IBD are located on chromosomes 3, 7, 12, and 16. Research is still in progress. It is believed that IBD is not only a polygenic disease, but also a genetically heterogeneous disease (different people are caused by different genes). Patients develop diseases due to genetic susceptibility under certain environmental factors. Third, infection The role of microbes in the pathogenesis of IBD has been paid attention to, but so far no specific microbial pathogen has been found to have a constant relationship with IBD. Some studies have suggested that Mycobacterium paratuberculosis and measles virus have a role in CD. Close, but the evidence is not convincing. An alternative view of microbial pathogenicity, which has received increasing attention in recent years, is that IBD (especially CD) is caused by an abnormal immune response against its own normal gut flora, supported by two lines of evidence On the one hand, from the animal model of IBD, the IBD animal model of immunodeficiency caused by transgenic or gene knockout method will not cause intestinal inflammation in the sterile environment of the intestinal tract, but if the normal flora state of the intestinal tract is restored, then Intestinal inflammation occurs,
“药食同源”是中华原创医学之中对人类最有价值的贡献之一;中医历来强调“药疗不如食疗”,食疗成为现代人追求返璞归真、健康饮食的最佳选择;让人们在享受美食的过程中祛除病痛,避免了打针、吃药,甚至手术之苦; "The same origin of medicine and food" is one of the most valuable contributions to human beings among the original Chinese medicine; traditional Chinese medicine has always emphasized that "medicine therapy is not as good as diet therapy", and diet therapy has become the best choice for modern people to pursue a return to nature and a healthy diet; let people enjoy Eliminate pain in the process of eating food, avoiding the pain of injections, medicine, and even surgery;
对于特殊营养食品,在美国、欧盟等发达国家都有相应的规定和开发应用;而我国GB29922-2013《特殊医学用途配方食品通则》食品安全国家标准中医学食品明确规定:2.1.1全营养配方食品:可作为单一营养来源满足目标人群营养需求的特殊医学用途配方食品;2.1.2特定全营养配方食品:可作为单一营养来源满足目标人群在特定疾病或医学状况下营养需求的特殊医学用途配方食品; For special nutritional food, there are corresponding regulations and development and application in the United States, the European Union and other developed countries; while my country's GB29922-2013 "General Rules for Formula Foods for Special Medical Purposes" national food safety standard Chinese medical food clearly stipulates: 2.1.1 Full nutritional formula Food: Formula food for special medical purposes that can be used as a single source of nutrition to meet the nutritional needs of the target population; 2.1.2 Specific complete nutritional formula food: formula for special medical purposes that can be used as a single source of nutrition to meet the nutritional needs of the target population under specific diseases or medical conditions food;
目前市场上有利用以食源性短肽为主要原料,添加药食两用的石斛、山楂、鸡内金、沙棘、木瓜、莱菔子等的提取物、复合维生素和矿物质,组成复合配方,还有利用新资源食品为主要原料的产品,但还没有发现结合炎性肠病患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以十种以上药食两用的中药提取物精华、益生元为主要原料,以短肽、氨基酸、碳水化合物、有保健功能的油脂、复合维生素、复合矿物质辅料制成的全营养配方食品、特定全营养配方食品、非全营养配方食品或类似产品。 At present, there are food-derived short peptides as the main raw material in the market, adding extracts, multivitamins and minerals such as dendrobium, hawthorn, gallinacea, seabuckthorn, papaya, radish, etc., which are used for both medicine and food, to form a compound formula. There are also products that use new resource food as the main raw material, but they have not been found to combine the physical characteristics of patients with inflammatory bowel disease. According to the essence theory of traditional Chinese medicine, it varies from person to person. The golden combination is more than ten kinds of traditional Chinese medicine that can be used for both medicine and food. Extract essence, prebiotics as the main raw materials, complete nutritional formula food made of short peptides, amino acids, carbohydrates, oils with health functions, multivitamins, and compound mineral supplementary materials, specific complete nutritional formula food, non-full nutritional formula food or similar products.
发明目的purpose of invention
本发明的目的是在继承中医精髓理论治病方法上,开创性将多种抗糖尿病新资源食品与“药食同源之中药”复方的提取物有机结合起来, 添加以短肽、氨基酸、碳水化合物、有保健功能的油脂、复合维生素、复合矿物质为辅料,不仅能够补充炎性肠病患者所必需营养素,改善机体营养状况,还能并利用药食两用中草药中的功能因子调节机体功能,毒副作用小、安全有效,且人们容易接受的适合炎性肠病患者食用的全营养配方食品、特定全营养配方食品或非全营养配方食品。 The purpose of the present invention is to creatively combine a variety of anti-diabetic new resource foods with the extracts of the "medicine and food homologous traditional Chinese medicine" compound, and add short peptides, amino acids, carbohydrates, etc. Compounds, oils with health care functions, multivitamins, and multiminerals are used as auxiliary materials, which can not only supplement the essential nutrients for patients with inflammatory bowel disease, improve the nutritional status of the body, but also use the functional factors in the dual-purpose Chinese herbal medicine to regulate body functions , a complete nutritional formula food, a specific complete nutritional formula food or a non-complete nutritional formula food that is suitable for patients with inflammatory bowel disease, has little toxic and side effects, is safe and effective, and is easily accepted by people.
发明内容:Invention content:
本研发团队根据《特殊医学用途配方食品通则》的要求,结合炎性肠病患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果,依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用一种或几种药食两用的中药提取物精华及新资源食品、短肽、益生元为主要原料,以氨基酸、碳水化合物、有保健功能的油脂、复合维生素、复合矿物质辅料,不仅可作为单一营养来源满足炎性肠病患者的营养需求,还有益胃生津、消积化滞、养阴清热、行气消食及防治炎性肠病的全营养配方食品、特定全营养配方食品或非全营养配方食品(组合成的复合配方); According to the requirements of the "General Rules for Formulated Foods for Special Medical Purposes", combined with the physical characteristics of patients with inflammatory bowel disease, and comprehensive research results of advanced physiology, medicine, nutrition and clinical application of Harvard University in the United States, according to the "Xiazhong Yuyu" The quintessence theory of traditional Chinese medicine (liver, spleen, and kidney are the principle of harmonization of the three viscera of the liver, spleen, and kidney), using the essence of one or several Chinese medicine extracts that are both medicinal and edible, as well as new resource foods, short peptides, Prebiotics are the main raw materials, amino acids, carbohydrates, fats with health care functions, multivitamins, and compound minerals are used as auxiliary materials. They can not only meet the nutritional needs of patients with inflammatory bowel disease as a single source of nutrition, but also benefit the stomach, promote body fluids, and eliminate accumulation. Full nutritional formula food, specific full nutritional formula food or non-full nutritional formula food (combined compound formula) for stagnation, nourishing yin and clearing heat, promoting qi and eliminating food, and preventing and treating inflammatory bowel disease;
本发明配方的主要成分为: The main component of formula of the present invention is:
1. 中药提取物是根据糖尿病患者的体质特征从中医理论中的肝、脾、肾三脏同调为主原则,利用药食两用中草药中的功能因子调节机体功能防治炎性肠病,并选取以下几大类药物进行配伍;其中: 1. According to the physical characteristics of diabetic patients, the Chinese medicine extract is based on the principle of the liver, spleen and kidney in the theory of traditional Chinese medicine. The functional factors in the medicinal and edible Chinese herbal medicine are used to regulate the body's function and prevent inflammatory bowel disease. The following major categories of drugs are compatible; among them:
石斛味甘,性微寒,能养阴清热,益胃生津,山楂所含的解脂酶能促进脂肪类食物的消化和促进胃液分泌和增加胃内酶素等功能,山楂具有消积化滞、收敛止痢、活血化淤等功效,主治饮食积滞、胸膈脾满、疝气血淤闭经等症,山楂中含有山萜类及黄酮类等药物成分,具有显著的扩张血管及降压作用,有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能,鸡内金性甘平、微寒、无毒,归脾、胃、肾、膀胱经,可消食健胃,涩精止遗,主治消积滞,健脾胃。治食积胀满,呕吐反胃,沙棘中含有的黄酮类化合物具有很高的药用价值,可降低胆固醇,缓解心绞痛发作,还有抗炎症的作用,木瓜中含有一种酵素,能消化蛋白质,有利于人体对食物进行消化和吸收有健脾消食的功效,含大量丰富的胡萝卜素、蛋白质、钙盐、蛋白酶、柠檬酶等,可以防治炎症,莱菔子消食除胀,降气化痰。用于饮食停滞、脘腹胀痛、大便秘结、积滞泻痢、痰壅喘咳,木香味辛、苦,性温;归脾、胃、肺经,行气止痛;调中导滞。主胞胁胀满足 ;脘腹胀痛;哎吐泄泻;痢疾后重,青皮具有疏肝破气,散结消痰的作用,能够治胸胁胃脘疼痛,疝气,食积,白术可以补脾,益胃,燥湿,和中,安胎,用于治脾胃气弱,不思饮食,猴头菇可以行气消食,健脾开胃,安神益智,用于食积不消,脘腹胀痛,脾虚食少,失眠多梦, Dendrobium is sweet in taste and slightly cold in nature. It can nourish yin and clear away heat, benefit the stomach and promote body fluid. The lipase contained in hawthorn can promote the digestion of fatty food, promote the secretion of gastric juice and increase the enzymes in the stomach. Hawthorn has the functions of eliminating accumulation and stagnation , astringent and dysentery, promoting blood circulation and removing blood stasis, etc. It is mainly used to treat food stagnation, fullness of the chest, diaphragm, spleen, hernia, blood stasis and amenorrhea. , has the functions of strengthening the myocardium, anti-arrhythmia, and regulating blood lipid and cholesterol levels. Chicken gold is sweet and flat, slightly cold, non-toxic, and belongs to the spleen, stomach, kidney, and bladder meridian. , Indications for eliminating stagnation, invigorating the spleen and stomach. Treat food accumulation, vomiting and nausea. The flavonoids contained in seabuckthorn have high medicinal value, which can lower cholesterol, relieve angina pectoris, and have anti-inflammatory effects. Papaya contains an enzyme that can digest protein. It is beneficial for the human body to digest and absorb food, and has the effect of invigorating the spleen and eliminating food. It contains a large amount of carotene, protein, calcium salt, protease, lemon enzyme, etc., which can prevent and treat inflammation. For dietary stagnation, abdominal distension and pain, constipation, stagnant diarrhea, phlegm stagnation, dyspnea and cough, woody fragrance is pungent, bitter, warm in nature; it returns to the spleen, stomach, and lung meridian, promotes qi and relieves pain; regulates the middle and guides stagnation. Indicates abdominal swelling and satisfaction; epigastric distension and pain; vomiting and diarrhea; severe after dysentery. Qingpi has the effect of soothing the liver and breaking qi, dispelling stagnation and eliminating phlegm. Stomach benefit, dampness, harmonization, anti-pregnancy, used to treat weak spleen and stomach qi, not thinking about eating, Hericium erinaceus can promote qi and eliminate food, invigorate the spleen and appetizer, soothe the nerves and improve intelligence, used for food accumulation, abdominal distension and pain, spleen deficiency Less, insomnia and more dreams,
本发明所述的药食两用中药提取物是指石斛、山楂、鸡内金、沙棘、木瓜、莱菔子、木香、青皮、白术、冬虫夏草、蛹虫草、生姜、猴头菇、砂仁、益智仁、肉豆蔻、钝顶螺旋藻、松花粉、麦芽、栀子、丁香、杏仁、佛手、甘草、乌梅、杏仁、葡萄干、胚芽米、纳豆、葛根、奇亚籽、圆苞车前子壳、青钱柳叶、茶树花、裸藻、天贝、广东虫草子、雪莲培养物、乳矿物盐其中的一种、几种或全部,采用生物酶解或预水解SBE提取并微胶囊化,经喷雾干燥及冷冻干燥的提取物全部混合; The medicinal and edible Chinese medicine extract of the present invention refers to dendrobium, hawthorn, gallinacea, seabuckthorn, papaya, radish, woody, green bark, Atractylodes macrocephala, cordyceps sinensis, Cordyceps militaris, ginger, Hericium erinaceus, amomum, Nutmeg, nutmeg, spirulina platensis, pine pollen, malt, gardenia, clove, almond, bergamot, licorice, dark plum, almond, raisin, rice germ, natto, kudzu root, chia seed, psyllium One, several or all of seed shells, Cyclocarya paliurus leaves, tea tree flowers, euglena, tempeh, Cordyceps guangdong, snow lotus culture, milk mineral salt , extracted by biological enzymatic or pre-hydrolyzed SBE and microencapsulated liquefied, spray-dried and freeze-dried extracts were all mixed;
2. 短肽:即为低聚肽,是指利用生物酶工程技术从动物或植物蛋白中分离提取的一类小分子蛋白质,其平均分子量在1000Dalton以下,易溶于水,对酸、热稳定,可以不需经过消化而直接吸收,生物利用率高,在吸收和利用上优于游离的氨基酸和完整的蛋白质,可应用于蛋白质补充食品中,尤其对于消化吸收能力低下的人群,短肽是极佳的氮源,除营养功能外,短肽还具有一系列的生理活性功能:提高小肠的消化吸收功能, 增强机体免疫力,抗氧化, 辅助调节血糖,辅助调节血脂,辅助降血压,抗辐射, 促进矿物质吸收, 增强药食两用中草药中功能因子的作用效果; 2. Short peptides: oligopeptides, which refer to a class of small molecular proteins that are isolated and extracted from animal or plant proteins by bio-enzyme engineering technology. The average molecular weight is below 1000Dalton, easily soluble in water, stable to acid and heat , can be directly absorbed without digestion, has high bioavailability, and is superior to free amino acids and complete proteins in absorption and utilization. It can be used in protein supplement foods, especially for people with low digestion and absorption capabilities. Short peptides are Excellent nitrogen source. In addition to nutritional functions, short peptides also have a series of physiologically active functions: improving digestion and absorption of the small intestine, enhancing immunity, anti-oxidation, assisting in regulating blood sugar, assisting in regulating blood lipids, assisting in lowering blood pressure, and anti-aging. Radiation, to promote mineral absorption, to enhance the effect of functional factors in Chinese herbal medicines;
本发明所述的短肽是指玉米低聚肽、小麦低聚肽、海洋胶原肽、海洋骨原肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽其中一种、几种或全部混合; The short peptide in the present invention refers to one, several or all of corn oligopeptides, wheat oligopeptides, marine collagen peptides, marine bone peptides, soybean protein peptides, whey protein peptides, and ovalbumin peptides;
3. 益生元: 以促益生菌肠道定植、肠道收敛、降低肠道pH环境,也不被大多数的肠道腐败菌利用,但可以促进人体内有益细菌——乳杆菌、双歧 杆菌的生长繁殖,从而可以抑制腐败菌生长,有助于改善和维持肠道正常功能;长期食用可以延缓衰老、通便、提高免疫力、减轻肝脏负担、提高营养素的吸收率,特别是能够改善机体对钙、铁、锌等金属离子 的吸收;可选择性地促进有益菌(双歧、乳酸)的生长繁殖外,还可代谢为酸性产物如乳酸等有机酸,使结肠内pH值降低,抑制肠道有害细菌的生长;使小肠内水电解质滞留在肠腔,产生高渗效果,刺激肠蠕动引起缓泻,从而促进肠道内毒素及其他毒性物质的排出,乳果糖还可直接灭活肠道中内毒素、降低肠道pH值,已广范应用于炎性肠病的治疗; 3. Prebiotics: To promote intestinal colonization of probiotics, intestinal convergence, lower intestinal pH environment, and not be used by most intestinal spoilage bacteria, but can promote beneficial bacteria in the human body - Lactobacillus, Bifidobacteria growth and reproduction, which can inhibit the growth of spoilage bacteria, and help to improve and maintain the normal function of the intestinal tract; long-term consumption can delay aging, laxative, improve immunity, reduce the burden on the liver, improve the absorption rate of nutrients, especially to improve the body Absorption of calcium, iron, zinc and other metal ions; it can selectively promote the growth and reproduction of beneficial bacteria (bifido, lactic acid), and can also be metabolized into acidic products such as lactic acid and other organic acids, reducing the pH value in the colon and inhibiting The growth of harmful bacteria in the intestinal tract; make the water and electrolyte in the small intestine stay in the intestinal cavity, produce a hypertonic effect, stimulate intestinal peristalsis and cause laxative, thereby promoting the discharge of intestinal toxins and other toxic substances, lactulose can also directly inactivate intestinal Toxins, lower intestinal pH, has been widely used in the treatment of inflammatory bowel disease;
本发明所述的益生元为:山药、茯苓、薏仁、鸡内金、芡实、菊粉的提取物、棉子低聚糖、水苏糖、酵母、低聚异麦芽糖、海藻糖、低聚果糖、大豆低聚糖、低聚木糖其中的一种、几种或全部混合; The prebiotics described in the present invention are: Chinese yam, poria cocos, coix seed, gallinacea, Gorgon fruit, extract of inulin, cottonseed oligosaccharide, stachyose, yeast, isomaltooligosaccharide, trehalose, fructooligosaccharide , soybean oligosaccharides, xylooligosaccharides, one, several or all mixed;
4.碳水化合物:碳水化合物是由碳、氢和氧三种元素组成,它是为人体提供热能的三种主要的营养素中最廉价的营养素,摄入充足时,在体内可迅速氧化及时提供能量,避免将宝贵的蛋白质用来提供能量,碳水化合物也是细胞膜的糖蛋白、神经组织的糖脂以及传递遗传信息的脱氧核糖核酸(DNA)的重要组成成分,而且碳水化合物中含有的糖原,当其在肝内储备充足时,肝细胞对某些有毒的化学物质和各种致病微生物产生的毒素有较强的解毒能力; 4. Carbohydrates: Carbohydrates are composed of three elements: carbon, hydrogen and oxygen. It is the cheapest nutrient among the three main nutrients that provide heat energy for the human body. When ingested sufficiently, it can be rapidly oxidized in the body to provide energy in time , avoid using precious protein to provide energy, carbohydrates are also important components of glycoproteins in cell membranes, glycolipids in nerve tissues, and deoxyribonucleic acid (DNA) that transmit genetic information, and glycogen contained in carbohydrates, when When its reserves in the liver are sufficient, the liver cells have a strong ability to detoxify certain toxic chemicals and toxins produced by various pathogenic microorganisms;
本发明所述的碳水化合物是指L-阿拉伯糖、果糖、蚌肉多糖、抗性糊精、壳寡糖、酵母β-葡聚糖、多聚果糖、半乳糖、乳糖、葡萄糖、麦芽糖、碳水化合物、有保健功能的油脂、、淀粉、糖元其中的一种、几种或全部混合; The carbohydrates described in the present invention refer to L-arabinose, fructose, mussel polysaccharide, resistant dextrin, chitosan oligosaccharide, yeast β-glucan, polyfructose, galactose, lactose, glucose, maltose, carbohydrate One, several or all of compounds, fats with health functions, starch, and glycogen are mixed;
5.有保健功能的油酯是指对人身体有保健作用,并能增加终产品能量,使本发明的终产品每100g所含有的能量应不低于295kJ(70kcal);如鱼油是人体血管的清道夫,还能预防动脉硬化、中风和心脏病。鱼油是高血压、冠心病、脑中风、糖尿病、风湿性关节炎、癌症等疾病;亚麻籽油有减肥、降低胆固醇、改善肾功能等作用;牡丹籽油有降血脂和降血压,增强自身免疫,预防糖尿病,防治癌症的功效;翅果油有防止和治疗高血压,高血脂,血管硬化等病症的功效; 5. The oil and ester with health care function means that it has a health care effect on the human body and can increase the energy of the final product, so that the energy contained in every 100g of the final product of the present invention should not be less than 295kJ (70kcal); It can also prevent arteriosclerosis, stroke and heart disease. Fish oil is effective for hypertension, coronary heart disease, stroke, diabetes, rheumatoid arthritis, cancer and other diseases; linseed oil has the effects of losing weight, lowering cholesterol, and improving kidney function; peony seed oil can lower blood fat and blood pressure, and enhance autoimmunity , prevent diabetes and prevent cancer; samara oil has the effect of preventing and treating hypertension, hyperlipidemia, vascular sclerosis and other diseases;
本发明所述的有保健功能的油脂是指亚麻籽油、牡丹籽油、翅果油、水飞蓟籽油、植物甾醇酯、御米油、茶叶籽油、鱼油、鱼油提取物、花生四烯酸油脂、蔗糖聚酯、DHA藻油、磷虾油、盐地碱蓬籽油、美藤果油、盐肤木果油、中链甘油三酯、黄明胶、光皮梾木果油、长柄扁桃油、中长链脂肪酸食用油、元宝枫籽油、表没食子儿茶素没食子酸酯、甘油二酯油、叶黄素酯其中的一种、几种或全部混合; The fats and oils with health care function described in the present invention refer to linseed oil, peony seed oil, samara oil, milk thistle seed oil, phytosterol ester, royal rice oil, tea seed oil, fish oil, fish oil extract, peanut four Alkenic acid oil, sucrose polyester, DHA algae oil, krill oil, Suaeda salsa seed oil, saponica fruit oil, salina fruit oil, medium-chain triglycerides, yellow gelatin, eucalyptus fruit oil, Long handle almond oil, medium and long chain fatty acid edible oil, ingot maple seed oil, epigallocatechin gallate, diglyceride oil, lutein ester, one, several or all mixed;
6.氨基酸:分为必需氨基酸与非必需氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性;摄取适量的蛋氨酸有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用;亮氨酸能够修复肌肉,控制血糖,并给身体组织提供能量,必需氨基酸苯丙氨酸可以抑制癌瘤生长,又可以降低药物的毒副作用,赖氨酸可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育;精氨酸有助于将血液中的氨转变为尿素而排泄出去;对于高氨血症,肝脏机能障碍等均有功效;组氨酸降低胃液酸度,缓和胃肠手术的疼痛,减轻妊娠期呕吐及胃部灼热感,抑制由植物神经紧张而引起的消化道溃烂,对过敏性疾病,如哮喘等也有功效;色氨酸可以预防糙皮病、抑郁症,改善睡眠和调节情绪; 6. Amino acid: divided into essential amino acid and non-essential amino acid, which is the basic unit of protein, endows protein with specific molecular structure and form, and makes it biochemically active; intake of appropriate amount of methionine is helpful for the metabolism of various sulfur-containing compounds in the human body And the methyl group contained in it can detoxify toxic substances or drugs through methylation; leucine can repair muscles, control blood sugar, and provide energy to body tissues; the essential amino acid phenylalanine can inhibit cancer growth, and can reduce the toxic and side effects of drugs, lysine can improve the absorption and utilization of food protein, achieve balanced nutrition, and promote growth and development; arginine helps to convert ammonia in the blood into urea and excrete it; for high Ammoniaemia, liver dysfunction, etc. are effective; histidine reduces the acidity of gastric juice, relieves the pain of gastrointestinal surgery, relieves vomiting during pregnancy and stomach burning sensation, inhibits digestive tract ulcers caused by autonomic nervous tension, and is effective for allergies Diseases, such as asthma, are also effective; tryptophan can prevent pellagra, depression, improve sleep and regulate mood;
本发明所述的氨基酸是指L-谷氨酰胺、γ-氨基丁酸、珠肽粉、蛋氨酸、异亮氨酸、酪氨酸、苯丙氨酸、赖氨酸、精氨酸、组氨酸、色氨酸、瓜氨酸、鸟氨酸、牛磺酸其中的一种、几种或全部混合; Amino acid in the present invention refers to L-glutamine, γ-aminobutyric acid, pearl peptide powder, methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine, histamine Acid, tryptophan, citrulline, ornithine, taurine, one, several or all mixed;
7.维生素和矿物质:维生素和矿物质是人体必需的营养素,本发明中添加的维生素为维生素和矿物质是人体必需的营养素; 7. Vitamins and minerals: vitamins and minerals are essential nutrients for the human body, and the vitamins added in the present invention are vitamins and minerals are essential nutrients for the human body;
本发明中添加的维生素为维生素A、维生素D、维生素E、维生素K、维生素K1、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、维生素Be、维生素Bu、烟酸、叶酸、泛酸、胆碱、生物素其中的 一种、几种或全部混合; The vitamins added in the present invention are vitamin A, vitamin D, vitamin E, vitamin K, vitamin K1, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin Be, vitamin Bu, niacin, folic acid, pantothenic acid, One, several or all of choline and biotin are mixed;
本发明中添加的矿物质为钙、磷、钾、钠、镁、氯、铁、锌、硒、铜、锰、碘、氟、铬、钼其中的一种、几种或全部混合,本发明所述的矿物质添加为该矿物质的有机或无机化合物; The minerals added in the present invention are calcium, phosphorus, potassium, sodium, magnesium, chlorine, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum, one, several or all of them mixed. The mineral is added as an organic or inorganic compound of the mineral;
本发明中维生素矿物质的添加量参照《特殊医学用途配方食品通则》执行,现以1000g成品为例,添加量为维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K0.0075g、维生素K10.00001g、维生素C10.625g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B0.0023g、维生素Be、维生素Bu、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、氯、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g; The amount of added vitamins and minerals in the present invention is implemented with reference to the "General Rules for Formulated Foods for Special Medical Purposes". Now taking 1000g of finished products as an example, the added amounts are 0.01g of vitamin A, 0.000015g of vitamin D, 0.12g of vitamin E, 0.0075g of vitamin K, Vitamin K10.00001g, vitamin C10.625g, vitamin B10.016g, vitamin B20.016g, vitamin B60.015g, vitamin B0.0023g, vitamin Be, vitamin Bu, niacin 0.2g, folic acid 0.003g, pantothenic acid 0.051g, bile Alkali 2.5g, biotin 0.000057g, calcium 6.2g, phosphorus 4.5g, potassium 10g, sodium 16.17g, magnesium 1.7g, chlorine, iron 0.15g, zinc 6.2g, selenium 0.00012g, copper 0.007g, manganese 0.018g, Iodine 0.00001g, fluorine 0.00001g, chromium 0.00001g, molybdenum 0.00001g;
8.采用上述集成创新工艺将各种配料混合均匀制成粉状的固体饮料、颗粒剂,并分装成10g/包,用约150ml开水溶解后,直接饮用或经鼻饲摄入;也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥,少添加黑芝麻粉等,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在洁净干燥环境内进行; 8. Use the above-mentioned integrated innovative process to mix various ingredients evenly to make powdered solid beverages and granules, and pack them into 10g/bags, dissolve them in about 150ml of boiling water, drink them directly or take them through nasal feeding; you can also add Appropriate amount of additives are made into capsules, tablets, or sweeteners and black sesame powder are added to make quick and convenient food such as biscuits, which are easy to carry and eat when going out. Packed into 10-65ml/bottle, drink one bottle every morning, noon, and 0.5 hours after dinner, all operations are carried out in a clean and dry environment;
本配方非全营养配方食品的特性及其对机体的作用主要表现在以下几个方面: The characteristics of this non-complete nutritional formula food and its effects on the body are mainly manifested in the following aspects:
1.本发明是根据《特殊医学用途配方食品通则》的要求,结合炎性肠病患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果研制的,因人而异,黄金配伍; 1. The present invention is developed according to the requirements of "General Rules for Formulated Foods for Special Medical Purposes", combined with the physical characteristics of patients with inflammatory bowel disease, and the research results of advanced physiology, medicine, nutrition and clinical application of Harvard University in the United States. Different people, golden combination;
2.本发明依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用多种药食两用的中药提取物精华、短肽为主要原料,以益生元、碳水化合物、氨基酸、有保健功能的油脂、多种维生素及矿物质为辅料,各种配料的有机组合,将各种功能进行融合,并通过有效成分之间的协同作用,增强作用效果; 2. The present invention is based on the quintessence theory of traditional Chinese medicine (liver, spleen, and kidney are the main principle of the same coordination of the liver, spleen, and kidney) based on the essence theory of "dispelling the middle and nourishing" and "balanced recuperation", and adopts a variety of medicinal and edible Chinese medicine extract essences, short-term Peptide is the main raw material, prebiotics, carbohydrates, amino acids, fats with health functions, multi-vitamins and minerals are used as auxiliary materials. The organic combination of various ingredients integrates various functions, and through the effective ingredients. Synergistic effect, enhance the effect;
3. 具有高效吸收性,利用本发明配方,各种组分采用适宜的比例搭配制备的食品,经一定量水溶解后呈等渗状态,能快速 通过胃到达小肠,吸收快速、完全,可以迅速补充炎性肠病患者所需营养,不增加肝肾负担; 3. It has high absorbability. Using the formula of the present invention, the food prepared with appropriate proportions of various components will be in an isotonic state after being dissolved in a certain amount of water, and can quickly pass through the stomach to the small intestine, absorb quickly and completely, and can quickly Supplement the nutrition needed by patients with inflammatory bowel disease without increasing the burden on liver and kidney;
4. 本发明配方中采用各种药食两用中草药的提取物,含有多种功能活性成分,不仅提高了功能因子的浓度,减少各种杂质的摄入,有助于减轻肝肾负担,具有增强人体抵抗力的作用,还有益胃生津、消积化滞、养阴清热、行气消食及防治炎性肠病的功效; 4. The formula of the present invention adopts the extracts of various medicinal and edible Chinese herbal medicines, and contains a variety of functional active ingredients, which not only increases the concentration of functional factors, reduces the intake of various impurities, and helps to reduce the burden on the liver and kidneys, it has It has the effect of enhancing the body's resistance, and it also has the effects of benefiting the stomach and promoting body fluid, eliminating stagnation, nourishing yin and clearing heat, promoting qi and eliminating food, and preventing and treating inflammatory bowel disease;
5.本发明配方食品以多种来源的食源性生物活性短肽为氮源,因为短肽不需消化即可吸收,更有利于机体的利用,可以有效改善炎性肠病患者负氮平衡,而且食源性短肽能够改善肠粘膜上皮细胞的结构和功能,提高肠粘膜的吸收能力; 5. The formula food of the present invention uses food-derived bioactive short peptides from various sources as the nitrogen source, because short peptides can be absorbed without digestion, which is more conducive to the utilization of the body, and can effectively improve the negative nitrogen balance of patients with inflammatory bowel disease , and food-derived short peptides can improve the structure and function of intestinal mucosal epithelial cells, and improve the absorption capacity of intestinal mucosa;
6.本发明配方中所含的益生元,通过促进肠内益生菌的生长繁殖,抑制腐败菌的生长,同时在肠粘膜表面形成一道保护屏障,可以抵御肠道腐败菌对肠粘 膜的损伤,减少肠内有害物质的吸收,还可以促进肠道蠕动,加速肠内残留物质的排出,可以防止便秘,而且通过促进肠道益生菌的生长繁殖也可以增强机体免疫力,短肽 与活性多糖等生物活性物质具有协同作用; 6. The prebiotics contained in the formula of the present invention can inhibit the growth of spoilage bacteria by promoting the growth and reproduction of probiotics in the intestine, and at the same time form a protective barrier on the surface of the intestinal mucosa, which can resist the damage of intestinal spoilage bacteria to the intestinal mucosa , reduce the absorption of harmful substances in the intestines, promote intestinal peristalsis, accelerate the discharge of residual substances in the intestines, prevent constipation, and enhance the body's immunity by promoting the growth and reproduction of intestinal probiotics, short peptides and active polysaccharides and other biologically active substances have a synergistic effect;
7.本发明配方中所含的碳水化合物是为人体提供热能的三种主要的营养素,在体内可迅速氧化及时提供能量,避免将宝贵的蛋白质用来提供能量,碳水化合物也是细胞膜的糖蛋白、神经组织的糖脂以及传递遗传信息的脱氧核糖核酸(DNA)的重要组成成分,而且碳水化合物中含有的糖原,当其在肝内储备充足时,肝细胞对某些有毒的化学物质和各种致病微生物产生的毒素有较强的解毒能力; 7. The carbohydrates contained in the formula of the present invention are three main nutrients that provide heat energy for the human body. They can be oxidized rapidly in the body to provide energy in time, and avoid using valuable protein to provide energy. Carbohydrates are also glycoproteins of cell membranes, Glycolipids in nervous tissue and important components of deoxyribonucleic acid (DNA) that transmit genetic information, and glycogen contained in carbohydrates, when it is fully stored in the liver, liver cells are resistant to certain toxic chemicals and various The toxin produced by a pathogenic microorganism has a strong detoxification ability;
8.本发明配方中所含的有保健功能的油脂不仅对人身体有保健作用,并为人体提供正常生活所需的能量,使本发明的终产品每100g所含有的能量应不低于295kJ(70kcal); 8. The oil with health-care function contained in the formula of the present invention not only has a health-care effect on the human body, but also provides the human body with the energy required for normal life, so that the energy contained in every 100g of the final product of the present invention should not be less than 295kJ (70kcal);
9.本发明配方中所含的氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性,有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用,能够修复肌肉,控制血糖,并给身体组织提供能量,还可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育; 9. The amino acid contained in the formula of the present invention is the basic unit of protein, endows protein with specific molecular structure, makes it have biochemical activity, helps the metabolism of various sulfur-containing compounds in the human body and the formazan contained in it The base can detoxify toxic substances or drugs by methylating them. It can repair muscles, control blood sugar, and provide energy to body tissues. It can also improve the absorption and utilization of food protein, achieve balanced nutrition, and promote growth and development;
10.本发明配方食品含多种维生素和矿物质,可迅速补充炎性肠病患者所需的微量营养素,短肽通过与钙、铁、锌等的螯合后,更增加了矿物质元素的吸收率; 10. The formula food of the present invention contains a variety of vitamins and minerals, which can quickly supplement the micronutrients needed by patients with inflammatory bowel disease. After the short peptide is chelated with calcium, iron, zinc, etc., the content of mineral elements is increased. Absorption rate;
11.本发明配方中不含脂肪和胆固醇,能够在补充蛋白质、微量营养素的同时,不会增加脂肪、胆固醇的摄入,避免了肉、蛋等髙蛋白食物的不利影响。 11. The formula of the present invention does not contain fat and cholesterol, and can not increase the intake of fat and cholesterol while supplementing protein and micronutrients, and avoids the adverse effects of high-protein foods such as meat and eggs.
具体实施方式 Detailed ways
下面通过以下实施案例对本发明作进一步说明,它将有助于理解本发明。 The present invention will be further described below through the following examples, which will help to understand the present invention.
实施案例一 Implementation Case 1
实现本发明目的炎性肠病非全营养配方食品是以结合炎性肠病患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以一种、几种或全部的药食两用中药提取物精华及新资源食品、益生元为主要原料,以一种、几种或全部的短肽、碳水化合物、氨基酸、有保健功能的油脂、多种维生素、多种矿物质为辅料制成的全营养配方,或制成特定全营养配方食品和非全营养配方食品; To achieve the purpose of the present invention, the non-complete nutritional formula food for inflammatory bowel disease is based on the physical characteristics of patients with inflammatory bowel disease, and according to the essence theory of traditional Chinese medicine, it varies from person to person. Dual-purpose traditional Chinese medicine extract essence, new resource food, and prebiotics are the main raw materials, and one, several or all short peptides, carbohydrates, amino acids, oils with health care functions, multi-vitamins, and multi-minerals are used as auxiliary materials Complete nutritional formula, or specific complete nutritional formula food and non-complete nutritional formula food;
按下列原料及其用量进行配方,药食两用的提取物及新资源食品:石斛12g、山楂12g、鸡内金11g、沙棘11g、木瓜10g、莱菔子10g、木香8g、青皮8g、白术8g、冬虫夏草7g、蛹虫草7g、生姜6g、猴头菇6g、砂仁6g、益智仁6g、肉豆蔻5g、钝顶螺旋藻5g、松花粉5g、麦芽5g、栀子4g、丁香4g、杏仁4g、佛手3g、甘草3g、乌梅3g、杏仁3g、葡萄干3g、胚芽米3g、纳豆3g、葛根3g、奇亚籽3g、圆苞车前子壳3g、青钱柳叶2g、茶树花2g、裸藻2g、天贝2g、广东虫草子2g、雪莲培养物1g、乳矿物盐1g、短肽200g、益生元100g、多种氨基酸100g、碳水化合物100g、有保健功能的油酯100g、维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K0.0075g、维生素K10.00001g、维生素C10.625g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B0.0023g、维生素Be、维生素Bu、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、氯、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g; Formulated according to the following raw materials and their dosage, extracts for medicinal and edible purposes and new resource food: Dendrobium 12g, hawthorn 12g, gallinaceae 11g, seabuckthorn 11g, papaya 10g, radish seed 10g, woody fragrance 8g, green bark 8g, Atractylodes macrocephala 8g, Cordyceps sinensis 7g, Cordyceps militaris 7g, Ginger 6g, Hericium erinaceus 6g, Amomum 6g, Yizhiren 6g, Nutmeg 5g, Spirulina platensis 5g, Pine pollen 5g, Malt 5g, Gardenia 4g, Clove 4g, 4g almonds, 3g bergamot, 3g licorice, 3g black plum, 3g almonds, 3g raisins, 3g germ rice, 3g natto, 3g kudzu root, 3g chia seeds , 3g psyllium husk , 2g paliurus leaves , tea tree flowers 2g , Euglena 2g , Tempeh 2g , Guangdong Cordyceps 2g , Snow Lotus Culture 1g, Milk Mineral Salt 1g, Short Peptide 200g, Prebiotics 100g, Various Amino Acids 100g, Carbohydrates 100g, Healthy Oils 100g, Vitamin A0.01g, Vitamin D0.000015g, Vitamin E0.12g, Vitamin K0.0075g, Vitamin K10.00001g, Vitamin C10.625g, Vitamin B10.016g, Vitamin B20.016g, Vitamin B60.015g, Vitamin B0.0023g, Vitamin Be, vitamin Bu, niacin 0.2g, folic acid 0.003g, pantothenic acid 0.051g, choline 2.5g, biotin 0.000057g, calcium 6.2g, phosphorus 4.5g, potassium 10g, sodium 16.17g, magnesium 1.7g, chlorine, Iron 0.15g, Zinc 6.2g, Selenium 0.00012g, Copper 0.007g, Manganese 0.018g, Iodine 0.00001g, Fluorine 0.00001g, Chromium 0.00001g, Molybdenum 0.00001g;
制作时先将以是石斛、山楂、鸡内金、沙棘、木瓜、莱菔子、木香、青皮、白术生姜、猴头菇、砂仁、益智仁、肉豆蔻、钝顶螺旋藻、松花粉、麦芽、栀子、丁香、杏仁、佛手、甘草、乌梅、杏仁、葡萄干、胚芽米、纳豆、奇亚籽、圆苞车前子壳、青钱柳叶、茶树花、裸藻、天贝浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的短肽、益生元、氨基酸、广东虫草子、冬虫夏草、蛹虫草、葛根、雪莲培养物、乳矿物盐、碳水化合物、有保健功能的油脂、多种维生素及矿物质一起粉碎混合后进行120摄氏度高温灭菌1小时,然后混合均匀制成粉状的固体饮料、颗粒剂,并分装成10g/包,用约150ml开水溶解后,直接饮用或经鼻饲摄入;也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥,少添加辅料等,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在符合《特殊医学用途配方食品良好生产规范》要求的洁净干燥环境内进行。 When making it, Dendrobium, hawthorn, gallinacea, seabuckthorn, papaya, radish, woody, green bark, Atractylodes ginger, Hericium erinaceus, amomum, Yizhiren, nutmeg, spirulina platensis, pine pollen , malt, gardenia, clove, almond, bergamot, licorice, ebony, almond, raisin, rice germ, natto, chia seed, psyllium husk, papaya leaf, tea tree flower, euglena, tempeh After soaking, add β-cyclodextrin, extract by pre-hydrolysis SBE technology, and spray-dry the powdery substance, then add short peptides, prebiotics, amino acids, Cantonese Cordyceps, Cordyceps sinensis, pupae Cordyceps, kudzu root, snow lotus culture, milk mineral salts , carbohydrates, oils with health functions, multi-vitamins and minerals are crushed and mixed together, then sterilized at 120 degrees Celsius for 1 hour, and then mixed evenly to make a powdered solid drink , granules, and divided into 10g/bag, dissolved in about 150ml of boiling water, drink directly or ingested through nasal feeding; it can also be made into capsules, tablets or sweeteners and black sesame powder by adding appropriate amount of additives Quick and convenient food such as biscuits is easy to carry and eat when going out. If it is made into a beverage, spray drying and less auxiliary materials are added, and it is divided into 10-65ml/bottle. Drink 1 bottle each morning, noon, and 0.5 hours after dinner. , all operations are carried out in a clean and dry environment that meets the requirements of the Good Manufacturing Practice for Formula Foods for Special Medical Purposes.
实施案例二 Implementation Case 2
上述炎性肠病非全营养配方食品还包括以重量计的下列组分,药食两用的提取物: 蛹虫草7g、生姜6g、猴头菇6g、砂仁6g、益智仁6g、肉豆蔻5g、钝顶螺旋藻5g、松花粉5g、麦芽5g、栀子4g、丁香4g、杏仁4g、佛手3g、甘草3g、乌梅3g、杏仁3g、葡萄干3g、胚芽米3g、纳豆3g、葛根3g、奇亚籽3g、圆苞车前子壳3g、青钱柳叶2g、茶树花2g、裸藻2g、天贝2g、广东虫草子2g、雪莲培养物1g、乳矿物盐1g、益生元350g、短肽150g、多种氨基酸100g、碳水化合物100g、有保健功能的油酯100g、碳水化合物、有保健功能的油脂、50g、维生素和矿物质25g。 The above inflammatory bowel disease non-complete nutritional formula food also includes the following components by weight, extracts for both medicine and food: Cordyceps militaris 7g, ginger 6g, Hericium erinaceus 6g, Amomum 6g, Yizhiren 6g, meat 5g cardamom, 5g spirulina platensis, 5g pine pollen, 5g malt, 4g gardenia, 4g clove, 4g almond, 3g bergamot, 3g licorice, 3g ebony, 3g almond, 3g raisin, 3g germ rice, 3g natto, kudzu root 3g, chia seeds 3g , psyllium husk 3g , Cyclocarya paliurus leaves 2g , tea tree flowers 2g , euglena 2g , tempeh 2g , guangdong cordyceps 2g , snow lotus culture 1g, milk mineral salt 1g , prebiotics 350g, 150g of short peptides, 100g of various amino acids, 100g of carbohydrates, 100g of oils and fats with health functions, 50g of carbohydrates, oils with health functions, 25g of vitamins and minerals.
实施案例三 Implementation Case Three
上述炎性肠病非全营养配方食品,还包括以重量计的下列组分:几种药食两用的中药提取物精华及新资源食品500g、益生元450g、短肽200g、有保健功能的油脂150g、氨基酸150g、多种维生素25g、多种矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。 The above-mentioned inflammatory bowel disease non-complete nutritional formula food also includes the following components by weight: several medicinal and edible Chinese medicine extract essences and new resource foods 500g, prebiotics 450g, short peptides 200g, 150g fat, 150g amino acid, 25g multivitamins, 25g multiminerals; the energy contained in each 100g should not be less than 295kJ (70kcal).
实施案例四 Implementation Case 4
上述炎性肠病非全营养配方食品,还包括以重量计的下列组分:药食两用中药提取物精华及新资源食品500g、益生元450g,碳水化合物300g、短肽250g、氨基酸150g、多种维生素25g、多种矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。 The above-mentioned inflammatory bowel disease non-complete nutritional formula food also includes the following components by weight: 500g of medicinal and edible Chinese medicine extract essence and new resource food, 450g of prebiotics, 300g of carbohydrates, 250g of short peptides, 150g of amino acids, 25g of multivitamins and 25g of multiminerals; the energy contained in each 100g should not be less than 295kJ (70kcal).
实施案例五 Implementation Case Five
上述炎性肠病非全营养配方食品,还包括以重量计的下列组分:药食两用中药提取物精华及新资源食品500g、益生元480g,短肽250g、碳水化合物250g、有保健功能的油脂150g、多种维生素25g、多种矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。 The above-mentioned inflammatory bowel disease non-complete nutritional formula food also includes the following components by weight: medicinal and edible dual-purpose traditional Chinese medicine extract essence and new resource food 500g, prebiotics 480g, short peptides 250g, carbohydrates 250g, with health care functions 150g of fat, 25g of multivitamins, and 25g of multiminerals; the energy contained in each 100g should not be less than 295kJ (70kcal).
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510195668.0A CN104839695A (en) | 2015-04-23 | 2015-04-23 | Non-complete nutritional formula food for inflammatory bowel disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510195668.0A CN104839695A (en) | 2015-04-23 | 2015-04-23 | Non-complete nutritional formula food for inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104839695A true CN104839695A (en) | 2015-08-19 |
Family
ID=53839990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510195668.0A Pending CN104839695A (en) | 2015-04-23 | 2015-04-23 | Non-complete nutritional formula food for inflammatory bowel disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104839695A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106306586A (en) * | 2016-08-23 | 2017-01-11 | 四川农业大学 | Nutritional composition resistant to erucic acid induced fish enteritis, using method, application and feed |
| CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
| CN107890563A (en) * | 2017-11-20 | 2018-04-10 | 中食都庆(山东)生物技术有限公司 | A kind of compound product with resistive connection enteritis function and preparation method thereof |
| CN108783471A (en) * | 2018-06-29 | 2018-11-13 | 山东探克生物科技股份有限公司 | A kind of dietary composition and preparation method thereof of Reduce allergy purpura disease |
| CN110742267A (en) * | 2019-11-11 | 2020-02-04 | 江南大学 | Total-nutrient formula food for inflammatory bowel diseases |
-
2015
- 2015-04-23 CN CN201510195668.0A patent/CN104839695A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106306586A (en) * | 2016-08-23 | 2017-01-11 | 四川农业大学 | Nutritional composition resistant to erucic acid induced fish enteritis, using method, application and feed |
| CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
| CN107890563A (en) * | 2017-11-20 | 2018-04-10 | 中食都庆(山东)生物技术有限公司 | A kind of compound product with resistive connection enteritis function and preparation method thereof |
| CN108783471A (en) * | 2018-06-29 | 2018-11-13 | 山东探克生物科技股份有限公司 | A kind of dietary composition and preparation method thereof of Reduce allergy purpura disease |
| CN110742267A (en) * | 2019-11-11 | 2020-02-04 | 江南大学 | Total-nutrient formula food for inflammatory bowel diseases |
| CN110742267B (en) * | 2019-11-11 | 2022-09-27 | 江南大学 | Complete nutritional formula food for inflammatory bowel disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104856003A (en) | Non-complete nutritional formula food for diabetes | |
| CN104855967A (en) | Non-complete nutritional formula food for obesity and fat reduction surgery | |
| CN104855985A (en) | High uric acid non-complete nutritional formula food | |
| CN104839707A (en) | Yin-deficiency constitution non-complete nutritional formula food | |
| CN104855994A (en) | Non-complete nutritional formula food for kidney disease | |
| CN104855975A (en) | Non-complete nutritional formula food for sarcopenia syndrome | |
| CN104839695A (en) | Non-complete nutritional formula food for inflammatory bowel disease | |
| CN104872638A (en) | Constipation Non-Complete Nutritional Formula Food | |
| CN104856000A (en) | Insomnia non-complete nutritional formula food | |
| CN104839708A (en) | Non-complete nutritional formula food for chronic obstructive pulmonary disease | |
| CN104839698A (en) | Non-Complete Nutritional Formula Foods for Cardiovascular Diseases | |
| CN104872646A (en) | Incomplete nutritional formula food for colorectal cancer | |
| CN104855978A (en) | Anti-aging Non-Complete Nutritional Formula Food | |
| CN104855970A (en) | Non-complete nutritional formula food for high blood pressure | |
| CN104839699A (en) | Non-complete nutritional formula food for heart disease | |
| CN104855992A (en) | Prostate Cancer Whole Nutritional Formula Food | |
| CN104855969A (en) | Non-complete nutritional formula food for liver disease | |
| CN104856002A (en) | Non-complete nutritional formula food for phlegm-dampness constitution | |
| CN104855976A (en) | Lowering three highs and strengthening yang non-complete nutritional formula food | |
| CN104839704A (en) | Aphrodisiac Non-Complete Nutritional Formula Food | |
| CN104856008A (en) | Non-full-nutrition formula food for atrophic gastritis | |
| CN104839709A (en) | Gastrointestinal malabsorption non-complete nutritional formula food | |
| CN104855966A (en) | Non-complete nutritional formula food for children | |
| CN104855971A (en) | Non-complete nutritional formula food for osteoma | |
| CN104872642A (en) | Pancreatitis Non-Complete Nutritional Formula Food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150819 |
|
| WD01 | Invention patent application deemed withdrawn after publication |